Results 171 to 180 of about 62,398 (280)

Engineered Elastin‐Like Polypeptides: Intelligent Self‐Assembling Platforms for Biomedical Application

Small Structures, Volume 7, Issue 3, March 2026.
Armed with unique structural and functional properties, elastin‐like polypeptides attract their attentions as programmable materials in biomedical applications, including fusion tags for protein and nucleic acid purification; nanocarriers for protein, chemotherapeutics, and imaging agent delivery; hydrogels for tissue regeneration, 3D model ...
Yang Yuan, Chen Zeng, Zichun Chen, Zhuoga Ciren, Qinran Yu, Chuanbo Wang, Hui Mao, Gang Li, Weizhi Chen, Xiqun Jiang   +9 more
wiley   +1 more source

Interferon regulatory factor 1 protects against chikungunya virus-induced immunopathology by restricting infection in muscle cells [PDF]

, 2017
Diamond, Michael S, Nair, Sharmila, Poddar, Subhajit, Shimak, Raeann M   +3 more
core   +2 more sources

Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients

Thoracic Cancer, Volume 17, Issue 6, March 2026.
Elderly lung cancer patients face increased risks of severe and fatal AEs during ICIs treatment. Reports concerning males, Asians, and anti‐PD‐1 recipients were associated with higher odds of a fatal outcome. Immune‐mediated pneumonitis is the most frequently reported severe AE, calling for heightened vigilance for these high‐risk subgroups.
Yumeng Tian, Xin Nie, Yue Yuan, Qian Wei, SiQi Zhang, Lin Li   +5 more
wiley   +1 more source

Clarifying the Diagnosis of Epstein-Barr Virus Related Myositis in a Genetically Confirmed Mitochondrial Diabetes Patient. [PDF]

Eur J Case Rep Intern Med
Picolos MK, Kyriakidou A, Papapostolou A, Papaetis GS.   +3 more
europepmc   +1 more source

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

Cancer Science, Volume 117, Issue 3, Page 749-758, March 2026.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Toyofumi F. Chen‐Yoshikawa, Yasushi Goto, Wataru Nishio, Shizuka Nakagawa, Morihiko Hayashi, Hirotsugu Kenmotsu   +9 more
wiley   +1 more source

Clinical Characteristics of Patients With Anti-Signal Recognition Particle Antibody: A Cohort Study. [PDF]

Immun Inflamm Dis
Jubber A, Durrani M, Almayahi A, Sunmboye K.   +3 more
europepmc   +1 more source

Impact of a Neurogenic Dysphagia Outpatient Clinic on Diagnosis, Treatment, and Nutrition

European Journal of Neurology, Volume 33, Issue 3, March 2026.
This retrospective study analyzed 255 patients evaluated at a university‐led neurogenic dysphagia outpatient clinic between 2021 and 2023. It assessed diagnostic, therapeutic, and nutritional outcomes using FEES‐based swallowing evaluations. The findings show that structured outpatient dysphagia care significantly enhances diagnostic precision, guides ...
Bendix Labeit, Jasmin Bach, Elena Harborth, Rainer Dziewas, Sven G. Meuth, Christian Grefkes, Laurent Willems, Sriramya Lapa   +7 more
wiley   +1 more source

Rapidly Progressive Overlap of Immune Checkpoint Inhibitor-Induced Myositis and Myasthenia Gravis: Diagnostic and Therapeutic Challenges. [PDF]

Cureus
Sequeira S, Borges C, Castro P, Barros N, Mendes M.   +4 more
europepmc   +1 more source

Concurrent Sporadic Late‐Onset Nemaline Myopathy and an Excessive Glycogen Accumulation Associated With Monoclonal Gammopathy

European Journal of Neurology, Volume 33, Issue 3, March 2026.
ABSTRACT Background Monoclonal gammopathy‐associated myopathies (MGAMs) include light chain (AL) amyloid myopathy, sporadic late‐onset nemaline myopathy (SLONM), and vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS). These subtypes usually occur separately, although rare overlap has been described. We report a patient with monoclonal
Felipe J. S. Jones, Ikreet Cheema, Ruple S. Laughlin, Eli Muchtar, Teerin Liewluck   +4 more
wiley   +1 more source

Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis. [PDF]

Semin Arthritis Rheum
Saygin D, Wang XY, Fitzgerald KC, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, Christopher-Stine L, Mecoli CA.   +9 more
europepmc   +1 more source